Trial · NCT04640168
Results by group420
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 420
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
The Proportion of Participants Not Meeting Criteria for One of the Following Two Ordinal Scale Categories at Any Time: 8) Death; 7) Hospitalized, on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation (ECMO) | Remdesivir Plus Baricitinib | 0.87 | 95% Confidence Interval 0.84 to 0.90 | Proportion of participants | |
The Proportion of Participants Not Meeting Criteria for One of the Following Two Ordinal Scale Categories at Any Time: 8) Death; 7) Hospitalized, on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation (ECMO) | Remdesivir Plus Dexamethasone | 0.88 | 95% Confidence Interval 0.84 to 0.90 | Proportion of participants | |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Baricitinib | Day 3 | 1.1 | 95% Confidence Interval -0.9 to 3.1 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Dexamethasone | Day 3 | 4.3 | 95% Confidence Interval 1.2 to 7.4 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Baricitinib | Day 5 | 6.0 | 95% Confidence Interval 0.8 to 11.2 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Dexamethasone | Day 5 | 15.9 | 95% Confidence Interval 11.6 to 20.1 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Baricitinib | Day 8 | 4.7 | 95% Confidence Interval -5.9 to 15.3 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Dexamethasone | Day 8 | 16.1 | 95% Confidence Interval 2.6 to 29.7 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Baricitinib | Day 11 | 5.6 | 95% Confidence Interval -2.0 to 13.2 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Dexamethasone | Day 11 | 15.5 | 95% Confidence Interval 4.1 to 26.9 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Baricitinib | Day 15 | 7.1 | 95% Confidence Interval -1.1 to 15.2 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Dexamethasone | Day 15 | 8.2 | 95% Confidence Interval -3.3 to 19.8 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Baricitinib | Day 29 | -3.8 | 95% Confidence Interval -16.3 to 1.0 | Units/Liter (U/L) |
| Change From Baseline in Alanine Aminotransferase (ALT) | Remdesivir Plus Dexamethasone | Day 29 | 1.1 | 95% Confidence Interval -26.3 to 18.5 | Units/Liter (U/L) |
| Change From Baseline in Aspartate Aminotransferase (AST) | Remdesivir Plus Baricitinib | Day 3 | -5.9 | 95% Confidence Interval -8.1 to -3.6 | U/L |
| Change From Baseline in Aspartate Aminotransferase (AST) | Remdesivir Plus Dexamethasone | Day 3 | -7.2 | 95% Confidence Interval -12.8 to -1.7 | U/L |
| Change From Baseline in Aspartate Aminotransferase (AST) | Remdesivir Plus Baricitinib | Day 5 | -4.0 | 95% Confidence Interval -11.9 to 3.9 | U/L |
| Change From Baseline in Aspartate Aminotransferase (AST) | Remdesivir Plus Dexamethasone | Day 5 | -8.5 | 95% Confidence Interval -13.1 to -4.0 | U/L |
| Change From Baseline in Aspartate Aminotransferase (AST) | Remdesivir Plus Baricitinib | Day 8 | -10.8 | 95% Confidence Interval -19.8 to -1.8 | U/L |
| Change From Baseline in Aspartate Aminotransferase (AST) | Remdesivir Plus Dexamethasone | Day 8 | -12.0 | 95% Confidence Interval -27.6 to 3.6 | U/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04640168/results